Related Experiment Video
Updated: Feb 3, 2026

A User-friendly and Powerful R Analysis of Large-scale Datasets
Published on: November 4, 2025
Methoxetamine: A foe or friend?
Chrislean Jun Botanas1, June Bryan de la Peña2, Hee Jin Kim1
1Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University, 815 Hwarangro, Nowon-gu, Seoul, 01795, Republic of Korea.
Abstract:
Methoxetamine (MXE) is an N-methyl-D-aspartate (NMDA) receptor antagonist that is chemically and pharmacologically similar to other dissociative substances, such as ketamine and phencyclidine. There are reports on the misuse of MXE, which sometimes resulted in adverse consequences and death. Studies have also shown that MXE has abuse liability and stimulates dopamine neurotransmission in the mesolimbic reward pathway in the brain. These findings have contributed to the negative impression on MXE. However, recent preclinical studies have identified the antidepressant properties of MXE, which are attributed to its ability to affect the glutamatergic and serotonergic systems. MXE is also reported to have analgesic effects. These findings show some of the "redeeming qualities" of MXE and indicate its possible therapeutic uses. In this paper, we have reviewed the findings that provide insights into the adverse and potential therapeutic effects of MXE. We compiled studies on the toxicity, psychotomimetic effects, and abuse liability of MXE, as well as its promising antidepressant and analgesic properties. We also have discussed the mechanism of action that might mediate the somewhat paradoxical effects observed. Importantly, this review provides valuable information on MXE for future research and will enable a better understanding of its psychopharmacological properties and the mechanisms responsible for its unique effects.
Insights
Methoxetamine (MXE), an NMDA receptor antagonist, shows potential antidepressant and analgesic effects despite risks of misuse. Further research is needed to understand its complex psychopharmacological properties and therapeutic potential.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Methoxetamine (MXE) is an NMDA receptor antagonist with similarities to ketamine and phencyclidine.
- Reports indicate MXE misuse can lead to adverse outcomes, including death, and it exhibits abuse liability.
- Preclinical studies suggest MXE possesses antidepressant and analgesic properties, contrasting with its known risks.
Purpose of the Study:
- To review and synthesize findings on the adverse effects and potential therapeutic benefits of Methoxetamine (MXE).
- To compile data on MXE's toxicity, psychotomimetic effects, abuse liability, and therapeutic properties.
- To discuss the mechanisms underlying MXE's paradoxical psychopharmacological effects.
Main Methods:
- Literature review of preclinical and clinical studies on Methoxetamine (MXE).
- Compilation of data on toxicity, psychotomimetic effects, abuse liability, and therapeutic actions.
- Analysis of proposed mechanisms of action for MXE's effects.
Main Results:
- MXE is associated with significant risks, including toxicity, psychotomimetic effects, and abuse potential.
- Evidence suggests MXE may have antidepressant effects via glutamatergic and serotonergic systems.
- Analgesic properties of MXE have also been reported in preclinical studies.
Conclusions:
- Methoxetamine (MXE) presents a complex profile with both significant risks and potential therapeutic applications.
- Understanding the mechanisms of action is crucial for evaluating MXE's dual psychopharmacological properties.
- This review provides a foundation for future research into MXE's therapeutic and adverse effects.
Related Concept Videos
Relationship Formation
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Stereotype Content Model
Framing Effects
Sternberg's Triangular Theory of Love
Social Facilitation

